|
|
|
|
|
04.08.26 - 12:36
|
InfuSystem Announces Financial Results for Second Quarter 2026 (Business Wire)
|
|
|
Net Revenues of $36.9 million Representing a 2.6% Increase from the Prior Year
Net income of $3.2 million
Adjusted EBITDA (non-GAAP) of $8.6 million
Adjusted EBITDA (non-GAAP) margin expanded by 1% to 23%
Reaffirms Full-Year 2026 GuidanceROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American:INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2026.
2026 Second Quarter Overview:
Net revenues totaled $36.9 million, an increase of 2.6% vs. prior year.
Patient Services net revenue was $24.8 million, an increase of 15% vs. prior year.
Device Solutions net revenue was $12.1 million, a decrease of 16% vs. prior year.
Gross profit was $21.4 million, an increase of 8% vs. prior year.
Gross margin was 58%, an increase of 3% vs. prior year.
Net income was $3.2 million, or $0.15 ...
|
|
|
28.07.26 - 12:33
|
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026 (Business Wire)
|
|
|
Investor Conference Call to be held 9:00 a.m. Eastern TimeROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens.The Company will also conduct a conference call for all interested parties on Tuesday, August 4, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company's website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 6164241 through Wednesday, November 4, 2026.About I...
|
|
|
|
|
18.05.26 - 22:36
|
InfuSystem Announces $20 Million Stock Repurchase Program (Business Wire)
|
|
|
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Company's Board of Directors has approved a stock repurchase program authorizing the Company to repurchase up to $20 million of the Company's outstanding common stock starting on July 1, 2026 and running through June 30, 2028. The program will supersede the previous authorization which is set to expire on June 30, 2026. Under the current authorization, the Company repurchased approximately 1.6 million shares of stock for approximately $11.9 million though March 31, 2026. Repurchases will be made through open market purchases, private transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”).
Ca...
|
|
|
|
|
|
|
07.05.26 - 12:33
|
InfuSystem Announces Financial Results for First Quarter 2026 (Business Wire)
|
|
|
Net Revenues of $33.7 million Representing a 3% Reduction from the Prior Year
Net income of $1.0 million
Adjusted EBITDA (non-GAAP) of $6.4 million
Adjusted EBITDA (non-GAAP) margin expanded by 1% to 19%
Reaffirms Full-Year 2026 GuidanceROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American:INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2026.
2026 First Quarter Overview:
Net revenues totaled $33.7 million, a decrease of 3% vs. prior year.
Patient Services net revenue was $22.1 million, an increase of 6% vs. prior year.
Device Solutions net revenue was $11.6 million, a decrease of 17% vs. prior year.
Gross profit was $19.7 million, an increase of 3% vs. prior year.
Gross margin was 58%, an increase of 3% vs. prior year.
Net income was $1.0 million, or $0.05 per di...
|
|
|
30.04.26 - 12:36
|
InfuSystem to Report First Quarter 2026 Financial Results on May 7, 2026 (Business Wire)
|
|
|
Investor Conference Call to be held 9:00 a.m. Eastern TimeROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2026 financial results on Thursday, May 7, 2026, before the market opens.
The Company will also conduct a conference call for all interested parties on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company's website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 1097864 through Thursday, May 14, 2026.
About InfuSyst...
|
|
|
|
|
|
|
|
|
24.02.26 - 12:36
|
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025 (Business Wire)
|
|
|
Full Year 2025 vs. Full Year 2024:
Seventh Consecutive Year of Record Net Revenues: $143.4 million, Up 6%
Net Income Increased to: $6.6 million, Up 183%
Record Adjusted EBITDA (non-GAAP): $31.5 million, Up 24%
Record Operating Cash Flow of $24.4 million, Up 19%:ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Fourth Quarter Overview:
Net revenues totaled $36.2 million, an increase of 7% vs. prior year.
Patient Services net revenue was $21.9 million, an increase of 5% vs. prior year.
Device Solutions net revenue was $14.4 million, an increase of 10% vs. prior year.
Gross profit was $20.4 million, an increase of 12% vs. prior year.
Gross margin was 56.4%, an increase of 2.6% vs. prior yea...
|
|
|
|
|
|
|
23.02.26 - 09:51
|
XFRA: MWBMU - HANDELSUNTERBRECHUNG - TEIL 1 (XETRA)
|
|
|
Unterbrechnung des Handels von im Spezialistenmodell der Fortlaufenden Auktion gehandelten Wertpapieren.
Aufgrund technischer Probleme wird der Handel in den unten benannten, vom Quoteverpflichteten MWBMU (MWB FAIRTRADE WERTPAPIERHANDELSBANK AG)
betreuten Wertpapieren unterbrochen.
Bestehende Orders werden nicht geloescht.
Sollten Sie Rueckfragen haben, wenden Sie sich bitte an Cash Markets Operations unter der Telefonnummer +49-69-211-11400
SG1CH4000003
GB00BNXM3P96
US52678P2056
SE0015809967
CNE100001QS1
PLDBENR00017
CNE1000070H8
US55406W1036
KYG1117K1141
CA7660871004
AU0000318552
CNE100006NX7
FR0013333077
GB0001110096
IE00BJ5FQX74
US25432X1028
CA5179071017
CA49804N1042
PLSTIGR00012
AU0000026122
JP3172060000
CA29764L1085
PLA346100011
CA2523711091
US78518H2022
KYG2159E1070
GB00BFPM8908
PLCRFRG00016
GB00BNVVGD77
KYG011251066
US12763L1052
AU0000012056
SE0015961404
AU0000426512
SE0017072267
JP3856000009
US28852N3070
AU0000165375
AU0000028367
CA4637731015
US09254V1...
|
|
|
17.02.26 - 12:33
|
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (Business Wire)
|
|
|
Investor Conference Call to be held 9:00 a.m. Eastern TimeROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the market opens.
The Company will also conduct a conference call for all interested parties on Tuesday, February 24, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company's website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 5092611 through T...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
